theory clinical_14_7
imports Main

begin

typedecl entity
typedecl event

consts
  BRCA2 :: "entity ⇒ bool"
  RAD51 :: "entity ⇒ bool"
  Repair :: "entity ⇒ bool"
  Humans :: "entity ⇒ bool"
  Involved :: "event ⇒ bool"
  Agent :: "event ⇒ entity ⇒ bool"
  Patient :: "event ⇒ entity ⇒ bool"
  Molecules :: "entity ⇒ bool"
  Binding :: "event ⇒ bool"
  Catalyze :: "event ⇒ bool"
  Joining :: "event ⇒ bool"
  Essential :: "event ⇒ bool"
  Promote :: "event ⇒ bool"
  Interaction :: "event ⇒ bool"
  In :: "entity ⇒ event ⇒ bool"
  Promotion :: "event ⇒ bool"
  Occur :: "event ⇒ bool"
  Via :: "event ⇒ entity ⇒ bool"

(* Explanation 1: BRCA2 and RAD51 homolog 1 are both involved in homologous recombination repair in humans. *)
axiomatization where
  explanation_1: "∃x y z e. BRCA2 x ∧ RAD51 y ∧ Repair z ∧ Humans w ∧ Involved e ∧ Agent e x ∧ Agent e y ∧ Patient e z"

(* Explanation 2: The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules, and this binding is essential for the promotion of joining undamaged homologous repair molecules. *)
axiomatization where
  explanation_2: "∃x y z w e1 e2 e3. BRCA2 x ∧ RAD51 y ∧ Molecules z ∧ Repair w ∧ Binding e1 ∧ Agent e1 x ∧ Agent e1 y ∧ Catalyze e2 ∧ Agent e2 x ∧ Patient e2 e3 ∧ Joining e3 ∧ Agent e3 z ∧ Essential e1 ∧ Promote e1 ∧ Patient e1 w"

(* Explanation 3: BRCA2, through its interaction with RAD51 homolog 1, promotes the joining of undamaged homologous repair molecules in humans, and this interaction is essential for the promotion process. *)
axiomatization where
  explanation_3: "∃x y z w e1 e2 e3. BRCA2 x ∧ RAD51 y ∧ Molecules z ∧ Humans w ∧ Interaction e1 ∧ Agent e1 x ∧ Agent e1 y ∧ Promote e2 ∧ Agent e2 x ∧ Patient e2 e3 ∧ Joining e3 ∧ Agent e3 z ∧ In w e3 ∧ Essential e1 ∧ Promote e1 ∧ Patient e1 e2"

(* Explanation 4: The promotion occurs via RAD51 homolog. *)
axiomatization where
  explanation_4: "∃x e. Promotion e ∧ RAD51 x ∧ Occur e ∧ Via e x"

theorem hypothesis:
  assumes asm: "BRCA2 x ∧ Molecules y ∧ RAD51 z ∧ Humans e1"
  (* Hypothesis: BRCA2 promotes the joining of undamaged homologous repair molecules via RAD51 homolog 1 in humans. *)
  shows "∃x y z e1 e2. BRCA2 x ∧ Molecules y ∧ RAD51 z ∧ Humans e1 ∧ Joining e2 ∧ Agent e2 y ∧ Promote e1 ∧ Agent e1 x ∧ Patient e1 e2 ∧ Via e1 z"
proof -
  (* From the known information, we have BRCA2 x, Molecules y, RAD51 z, and Humans e1. *)
  from asm have "BRCA2 x ∧ Molecules y ∧ RAD51 z ∧ Humans e1" <ATP>
  
  (* Explanation 3 states that BRCA2, through its interaction with RAD51 homolog 1, promotes the joining of undamaged homologous repair molecules in humans. *)
  (* This implies that there exists an event e2 such that Joining e2, Agent e2 y, Promote e1, Agent e1 x, and Patient e1 e2. *)
  from explanation_3 have "∃e2. Joining e2 ∧ Agent e2 y ∧ Promote e1 ∧ Agent e1 x ∧ Patient e1 e2" <ATP>
  
  (* Explanation 4 states that the promotion occurs via RAD51 homolog. *)
  (* This implies that there exists an event e1 such that Via e1 z. *)
  from explanation_4 have "Via e1 z" <ATP>
  
  (* Combining the results from explanation_3 and explanation_4, we can conclude the hypothesis. *)
  then show ?thesis <ATP>
qed

end
